Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen D Quint

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
JAMA Dermatology|December 6, 2018
Aggressive Squamous Cell Carcinoma in Organ Transplant RecipientsJoana Lanz, Jan Nico Bouwes Bavinck, Marlies Westhuis, et al.
Blood Neoplasia|June 2, 2025
Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasmsAstrid G S van Halteren, Paul G Kemps, Jelske Forma-Borst, et al.
The American Journal of Surgical Pathology|June 13, 2025
IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center LymphomaAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2017
Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma GroupRutger C Melchers, Rein Willemze, Laurien A Daniëls, et al.
Blood|January 25, 2020
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous diseaseRutger C Melchers, Rein Willemze, Joost S P Vermaat, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samplesKoen D Quint, Daan T Geraets, Henk A M van den Munckhof, et al.
Open Forum Infectious Diseases|March 21, 2022
Treatment and Outcome of Culture-Confirmed <i>Mycobacterium marinum</i> DiseaseLouise Hendrikx, Colette L M van Hees, Jurriaan E M de Steenwinkel, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
JAMA Dermatology|December 6, 2018
Aggressive Squamous Cell Carcinoma in Organ Transplant RecipientsJoana Lanz, Jan Nico Bouwes Bavinck, Marlies Westhuis, et al.
Blood Neoplasia|June 2, 2025
Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasmsAstrid G S van Halteren, Paul G Kemps, Jelske Forma-Borst, et al.
The American Journal of Surgical Pathology|June 13, 2025
IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center LymphomaAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2017
Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma GroupRutger C Melchers, Rein Willemze, Laurien A Daniëls, et al.
Blood|January 25, 2020
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous diseaseRutger C Melchers, Rein Willemze, Joost S P Vermaat, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samplesKoen D Quint, Daan T Geraets, Henk A M van den Munckhof, et al.
Open Forum Infectious Diseases|March 21, 2022
Treatment and Outcome of Culture-Confirmed <i>Mycobacterium marinum</i> DiseaseLouise Hendrikx, Colette L M van Hees, Jurriaan E M de Steenwinkel, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Pageof 9